Vascular nano stents

Nanotechnology for the Regeneration of Hard and Soft Tissues

Volumn , Issue , 2007, Pages 181-200

  Haberstroh, Karen M ^a  

^a Brown University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOTECHNOLOGY;

NANOSTRUCTURED MATERIALS;

EID: 84969594430     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812779656_0006     Document Type: Chapter

References (50)

1. Marieb EN. (2001) Human Anatomy & Physiology 5th Edition, Benjamin Cummings, New York.
2. Marschall SR and Patterson C. (2005) Principles of Molecular Cardiology, Humana Press, New Jersey.
3. Tortora GJ and Grabowksi SR. (2000) Principles of Anatomy and Physiology 9th Edition, John Wiley and Sons, New York.
4. White RA. (1989) Atherosclerosis and Arteriosclerosis, CRC Press, Florida.
5. Simionescu N and Simionescu M. Endothelial Cell Dysfunction, Plenum Press, New York and London.
6. Lusis AJ. (2000) Artherosclerosis Nature 407: 233-241 (2000).
7. Hoffman GS and Weyand CM. (2002) Inflammatory Diseases of Blood Vessel, Marcel Dekker, New York.
8. Topper JN and Gimbrone MA Jr. (1999) Artherosclerosis. Molecular Medicine Today 5: 40-46.
9. White RA and Hollier LH. (2005) Vascular Surgery: Basic Science and Clinical Correlations 2nd Edition, Blackwell Publishing, Massachusetts.
10. Hansson GK. (2001) Drug eluting stents. Arterioscler Thromb Vasc Biol 21(12):1876-90.
11. Robenek H and Severs NJ. (1992) Cell Interactions in Atherosclerosis CRC Press, Boca Raton.
12. Blake GJ and Ridker PM. (2001). Metal stents Circ Res 89(9): 763-71.
13. Heart Center Online at www.heartcenteronline.com
14. Linde J and Strauss BH. (2001) Pharmacological treatment for prevention of restenosis Expert Opin Emerg Drugs 6(2): 281-302.
15. van der Hoeven BL, Pires NM, Warda HM, Oemrawsingh PV, van Vlijmen BJ, Quax PH, Schalij MJ, van der Wall EE, and Jukema JW. (2005) Drug eluting stents:results, promises, problems. Int J Cardiol 99: 9-17.
16. Gotman I. (1997) Characteristics of metals used in implants. J Endourol 11: 383-9
17. Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, Leon MB, Fink S, Marin L, and Lansky AJ. (2003) Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol 92(4): 463-6.
18. Sketch MH Jr, Ball M, Rutherford B, Popma JJ, Russell C, and Kereiakes DJ. (2005) Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. Am J Cardiol 95(1): 8-12.
19. University Health Systems of Eastern Carolina at www.uhseast.com
20. Plant SD, Grant DM, and Leach L. (2005) Behaviour of human endothelial cells on surface modified NiTi alloy..Biomaterials 26(26): 5359-67.
21. Goodman SL, Sims PA, and Albrecht RM. (1996) Mimicking the roughness of vascular tissue. Biomaterials 17(21): 2087-95.
22. Thapa A, Webster TJ, and Haberstroh KM. (2003) Polymers with nano-dimensional surface features enhance bladder smooth muscle cell adhesion. Journal of Biomedical Materials Research 67A(4): 1374-83.
23. Thapa A, Miller DC, Webster TJ, and Haberstroh KM. (2003) Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials 24(17): 2915-2926.
24. Pattison MA, Webster TJ, Wurster S, and Haberstroh KM. (2005) Threedimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications Biomaterials 26(15): 2491-500.
25. Miller DC, Thapa A, Haberstroh KM, and Webster TJ. (2004) Mechanisms of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films. Biomaterials 25(1): 53-61.
26. Webster TJ, Ergun C, Doremus RH, Siegel RW, and Bizios R. (2000) Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials.21(17): 1803-10.
27. Webster TJ and Ejiofor JU. (2004) Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials 25(19): 4731-9.
28. Park GE, Pattison MA, Park K, and Webster TJ. (2005) Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials 26(16): 3075-82.
29. Choudhary S, Berhe M, Haberstroh KM, and Webster TJ. (2006). Increased vascular cell adhesion on nanostructured metals. International Journal of Nanotechnology 1(1): 41-49.
30. Messer RL, Wataha JC, Lewis JB, Lockwood PE, Caughman GB, and Tseng WY. (2005) Metal stents. J Long-term Effects of Medical Implants 15(1): 39-47.
31. Huang Y, Salu K, Wang L, Liu X, Li S, Lorenz G, Wnendt S, Verbeken E, Bosmans J, Van de Werf F, and De Scheerder I. (2005) Use of tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model. J Invasive Cardiol 17:142-148.
32. Moreno R and Macaya C. (2005) Stent-based delivered anti-proliferative drugs in the prevention of coronary stent restenosis. Curr Med Chem Cardiovasc Hematol Agents 3(3): 221-9.
33. Donners MM, Daemen MJ, Cleutjens KB, and Heeneman S. (2003) Inflammation and restenosis: implications for therapy. Ann Med 35: 523-31.
34. Tan L, Crone WC, and Sridharan K. (2002) J Mater Sci Mater Med 13(5): 501-8.
35. Oparaugo PC, Clarke IC, Malchau H, and Herberts P. (2001) Correlation of wear debris-induced osteolysis and revision with volumetric wear-rated of polyethylene: a survey of 8 reports in the literature. Acta Orthop Scand 72: 22-28.
36. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, and Peoc’h M. (2000). Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Jt Surg Am 82: 457-476.
37. Hashiguchi T, Hirano T, Shindo H, and Baba K. (1999) Wear of alumina prosthesis. Arch Orthop Trauma Surg 119: 30-34.
38. Kobayashi A, Bonfield W, Kadoya Y, Yamac T, Freeman MA, Scott G, and Revell PA. (1997) The size and shape of particulate polyethylene wear debris in total joint replacements. Proceedings of the Institution of Mechanical Engineering Part H - J Eng Med 211: 11-15.
39. Lerouge S, Huk O, Yahia LH, and Sedel L. (1996) Characterization of in vivo wear debris from ceramic-ceramic total hip arthroplasties. J Biomed Mater Res 32: 627-633.
40. Savio JA III, Overcamp LM, and Black J. (1994) Size and shape of biomaterial wear debris. Clin Mater 15: 101-147.
41. Buly RL, Huo MH, Salvati E, Brein W, and Bansal M. (1992) Wear debris in failed cemented total hip arthroplasty. An analysis of 71 cases. J. Arthroplasty 7: 315-323.
42. Schanbhag AS, Jacobs JJ, Black J, Galante JO, and Glant TT. (1997) Glant, Effects of particles on fibroblast proliferation and bone resorption in vitro. Clin Orthop Relat Res 342: 205-217.
43. Green TR, Fisher J, Stone M, Wroblewski BM, and Ingham E. (1998) Polyethylene particles of a ‘critical size’ are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19: 2297-2302.
44. Pioletti DP, Takei H, Kwon Sym Wood D, and Sung KL. (1999). The cytotoxic effect of titanium particles phagocytosed by osteoblasts. J Biomed Mater Res 46:399-407.
45. Kohilas K, Lyons M, Lofthouse R, Frondoza CG, Jinnah R, and Hungerford DS. (1999) Effect of prosthetic titanium wear debris on mitogen-induced monocyte and lymphoid activation. J Biomed Mater Res 47: 95-103.
46. Lohmann CH, Schwartz Z, Koster G, Jahn U, Buchhorn GH, MacDougall MJ, Casasola D, Liu Y, Sylvia VL, Dean DD, and Boyan BD. (2000) Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition. Biomaterials 21: 551-561.
47. Kwon SY, Takei H, Pioletti DP, Lin T, Ma QJ, Akeson WH, Wood DJ, and Sung KL. (2000) Titanium particles inhibit osteoblast adhesion to fibronectin-coated substrates. J Orthop Res 18: 203-211.
48. DeHeer DH, Engles JA, DeVries AS, Knapp RH, and Beebe JD. (2001). In situ complement activation by polyethylene wear debris. J Biomed Mater Res 54: 12-19.
49. Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, and Glant TT. (2001) The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Jt Surg Am 83: 201-211.
50. Gutwein LG and Webster TJ. (2004) Increased viable osteoblast density in the presence of nanophase compared to conventional alumina and titania particles Biomaterials 25(18): 4175-83.